DNA blood tests can tell baby's sex at 7 weeks: study

Afp
Thursday 11 August 2011 00:00 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Tests that measure DNA in a pregnant woman's blood work well for telling the sex of a baby after seven weeks' gestation without posing danger to the fetus, a US study said Tuesday.

The meta-analysis of previous studies on the topic suggests that using cell-free fetal DNA from the mother's blood is more accurate than a urine test or sonogram and is safer than amniocentesis.

It can also be done earlier than an ultrasound, which is usually accurate from 11 to 14 weeks, or amniocentesis, which samples fluid from the sac surrounding the fetus and carries a small risk of miscarriage.

"The availability of a reliable noninvasive alternative to determine fetal sex would reduce unintended fetal losses and would presumably be welcomed by pregnant women carrying fetuses at risk for disorders," said the study in the Journal of the American Medical Association.

The review included 57 studies, representing 3,524 male-bearing pregnancies and 3,017 female-bearing pregnancies, and found an accuracy rate of 95 to nearly 99 percent.

The technology to detect cell-free circulating Y-chromosome DNA sequences in the plasma of pregnant women has been around since 1997.

Many countries in Europe, including France, Spain, Britain and the Netherlands, routinely offer the test to pregnant women.

Some companies also sell the tests to consumers over the Internet.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in